Bharvin Kumar Patel

Person

Wetsfield, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination therapy with notch and PD-1 or PD-L1 inhibitors
- Patent number 11,826,317
- Issue date Nov 28, 2023
- Eli Lilly and Company
- Mark Harrath Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy with Notch and PI3K/mTOR inhibitors for use in...
- Patent number 11,564,929
- Issue date Jan 31, 2023
- Eli Lilly and Company
- Bharvin Kumar Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl...
- Patent number 10,787,460
- Issue date Sep 29, 2020
- Eli Lilly and Company
- David Andrew Coates
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy with Notch and PD-1 or PD-L1 inhibitors
- Patent number 10,688,104
- Issue date Jun 23, 2020
- Eli Lilly and Company
- Mark Harrath Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Notch pathway signaling inhibitor compounds
- Patent number 10,450,317
- Issue date Oct 22, 2019
- Eli Lilly and Company
- Julia Marie Clay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 9,000,023
- Issue date Apr 7, 2015
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 8,273,742
- Issue date Sep 25, 2012
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulation of survivin expression
- Patent number 7,541,344
- Issue date Jun 2, 2009
- Eli Lilly and Company
- Balkrishen Bhat
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and...
- Patent number 6,368,828
- Issue date Apr 9, 2002
- The United States of America as represented by the Department of Health and H...
- William LaRochelle
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS
- Publication number 20220008432
- Publication date Jan 13, 2022
- Eli Lilly and Company
- Mark Harrath BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH NOTCH AND PI3K/MTOR INHIBITORS FOR USE IN...
- Publication number 20210177859
- Publication date Jun 17, 2021
- Eli Lilly and Company
- Bharvin Kumar PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL...
- Publication number 20210032257
- Publication date Feb 4, 2021
- Eli Lilly and Company
- David Andrew Coates
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL...
- Publication number 20200017513
- Publication date Jan 16, 2020
- Eli Lilly and Company
- David Andrew COATES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS
- Publication number 20190192531
- Publication date Jun 27, 2019
- Eli Lilly and Company
- Mark Harrath BENDER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL FOR INHIBITING CDK7
- Publication number 20190144456
- Publication date May 16, 2019
- Eli Lilly and Company
- David Andrew Coates
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOTCH PATHWAY SIGNALING INHIBITOR COMPOUNDS
- Publication number 20180148456
- Publication date May 31, 2018
- Eli Lilly and Company
- Julia Marie Clay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20120316174
- Publication date Dec 13, 2012
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of treating a cancer with a survivin antisense oligonucleoti...
- Publication number 20120022140
- Publication date Jan 26, 2012
- Eli Lilly and Company
- Bharvin Kumar Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20100324048
- Publication date Dec 23, 2010
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATION OF SURVIVIN EXPRESSION
- Publication number 20090203896
- Publication date Aug 13, 2009
- Balkrishen Bhat
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Modulation of survivin expression
- Publication number 20070161547
- Publication date Jul 12, 2007
- Balkrishen Bhat
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Bharvin Kumar Patel

Person

Patents Grantslast 30 patents

Combination therapy with notch and PD-1 or PD-L1 inhibitors

Combination therapy with Notch and PI3K/mTOR inhibitors for use in...

(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl...

Combination therapy with Notch and PD-1 or PD-L1 inhibitors

Notch pathway signaling inhibitor compounds

Disubstituted phthalazine hedgehog pathway antagonists

Disubstituted phthalazine hedgehog pathway antagonists

Modulation of survivin expression

Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and...

Patents Applicationslast 30 patents

COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS

COMBINATION THERAPY WITH NOTCH AND PI3K/MTOR INHIBITORS FOR USE IN...

(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL...

(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL...

COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS

COMPOUNDS USEFUL FOR INHIBITING CDK7

NOTCH PATHWAY SIGNALING INHIBITOR COMPOUNDS

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

Method of treating a cancer with a survivin antisense oligonucleoti...

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

MODULATION OF SURVIVIN EXPRESSION

Modulation of survivin expression